FDA Alerts

Pharmacist- Versus Physician-Obtained Medication Histories
Reeder TA, Mutnick A
Am J Health Syst Pharm. 2008;65:857-860

Study Summary
About 60% of hospitalized patients have at least 1 error in their medication history that is taken upon admission.[1] The investigators in this study compared medication histories that were obtained by hospital pharmacists with those obtained by physicians. The study was prospective and included 55 patients, age 18 or older, admitted to the internal medicine service at a major teaching hospital. Within several hours of admission, a physician from the internal medicine service obtained a medication history from the patient as part of the overall history and physical examination. Subsequently, within 24 hours of admission, a pharmacist interviewed patients to obtain additional relevant medication history, such as dosages, dosing schedule, use of nonprescription medications and supplements, allergies, pregnancy and lactation status, and vaccination status.

Laboratory testing by the U.S. Food and Drug Administration has confirmed that both a sample of serrano pepper and a sample of irrigation water collected by agency investigators on a farm in the state of Tamaulipas, Mexico (business address is in Nuevo Leon, Mexico) contain Salmonella Saintpaul with the same genetic fingerprint as the strain of bacteria that is causing the current outbreak in the United States.

Manufacturer for Wegmans Brand Sorbet Issues an Allergen Alert for Undeclared Milk on a Limited Number of Wegmans Brand Sorbets.

The manufacturer of Wegmans Sorbet is recalling a limited number of 16 oz. Wegmans brand Sorbets because they may contain undeclared milk. People who have an allergy to milk run the risk of a serious or possible life-threatening allergic reaction if they consume the affected products listed below.

European regulators have approved a breakthrough new medication to help patients emerge far more quickly from anesthesia than existing treatments, the drug's maker Schering-Plough Corp said on Tuesday.

The drug, called Bridion, was approved by the European Commission, following a recommendation last month by an advisory panel in support of the drug, also known as sugammadex.